Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

378
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
378
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

199
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
199
Allergic Reactions02:06

Allergic Reactions

27.3K
Overview
27.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

261
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
261
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

383
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
383

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Measuring the effect of azithromycin in chronic respiratory disease using continuous cough monitoring: an open-label exploratory trial.

ERJ open research·2026
Same author

A Conversation Aid for Climate Conscious Inhaler Prescribing.

Chest·2026
Same author

Anaphylaxis and Epinephrine Use in Pregnancy.

The journal of allergy and clinical immunology. In practice·2026
Same author

Characterizing the nasal microbiome using a nasal allergen challenge model.

The Journal of allergy and clinical immunology·2026
Same author

Low risk of ocular toxicity following topical ocular administration of epinephrine nasal spray: implications for unintentional exposure.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same author

Clinical symptoms and biomarkers of cat allergen-induced allergic rhinitis using the nasal allergen challenge model.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same journal

A qualitative study of the impact of the COVID-19 pandemic on healthcare access and service delivery for people living with chronic obstructive pulmonary disease and asthma.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Preventive effect of heat-killed Lactiplantibacillus plantarum FM8 in an ovalbumin-induced food allergy murine model.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Mepolizumab reduces healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps: a linked EMR and claims-based pre-post study.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Triggers, clinical spectra and outcomes of pediatric anaphylaxis in a tertiary center: impact of comorbidities and cofactors on severity.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Declining venom immunotherapy: patient characteristics and clinical outcomes.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Longitudinal FeNO monitoring in pediatric asthma: association of FeNO and its trajectory patterns with asthma control status.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
查看所有相关文章

相关实验视频

Updated: Jun 17, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.3K

加拿大的集中过敏性鼻炎实践参数.

Anne K Ellis1, Victoria Cook2, Paul K Keith3

  • 1Division of Allergy & Immunology, Department of Medicine, Queen's University, Kingston, ON, Canada. anne.ellis@kingstonhsc.ca.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
|August 8, 2024
PubMed
概括
此摘要是机器生成的。

加拿大对过敏性鼻炎 (AR) 治疗的实践参数证实了血清特异性IgE或皮肤刺伤测试对免疫疗法候选人是可以接受的. 它还澄清了AR管理的第一线治疗选择和免疫治疗选择.

更多相关视频

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

426
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
06:34

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

10.0K

相关实验视频

Last Updated: Jun 17, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.3K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

426
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
06:34

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

10.0K

科学领域:

  • 过敏和免疫学 过敏和免疫学
  • 药物治疗 药物治疗
  • 临床实践指南 临床实践指南

背景情况:

  • 过敏性鼻炎 (AR) 是加拿大的常见疾病,影响所有年龄组.
  • 现有的AR管理指南显示区域差异和不同的药物治疗批准.
  • 这个专注的实践参数解决了加拿大AR治疗的六个关键研究问题.

研究的目的:

  • 为加拿大过敏性鼻炎的临床管理提供基于证据的建议.
  • 解决有关AR诊断,药物治疗和免疫治疗的具体研究问题.
  • 引导医疗保健专业人员优化AR治疗策略.

主要方法:

  • 对2016年以来发表的研究进行了文献评论.
  • 收集了证据,以支持对六个关于AR治疗的定义研究问题的答案.
  • 一个工作组根据综合证据制定了建议.

主要成果:

  • 血清特异性IgE和皮肤刺伤测试都可接受用于诊断AR和指导免疫治疗.
  • 鼻内皮质类固醇 (INCS) 通常是第一线,但患者/提供者偏好可能有利于第二代口服抗胰岛素 (OAH).
  • 结合性鼻内抗胰岛素/INCS配方优于INCS加OAH;对于大多数症状,LTRAs对OAH提供了有限的益处,但可能有助于夜间症状和喘患者.
  • 语言下免疫疗法 (SLIT) 和皮下免疫疗法 (SCIT) 的选择取决于除了疗效之外的多个因素,尽管疗效数据支持广泛使用这两种疗法.

结论:

  • 针对AR和免疫治疗候选人的诊断测试可以使用血清特异性IgE或皮肤刺伤测试.
  • 对AR的治疗决策应考虑患者和处方者的偏好,INCS和OAH是可行的一线选择.
  • 结合INAH/INCS疗法比INCS加OAH更有效;对于AR患者,应广泛考虑SLIT和SCIT等免疫疗法选择.